SKYLER FRYE: Open Payments
NPI 1508490129 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 92 payments from 13 companies in 2025. Trend: 2023 $718 · 2024 $2,181 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $326 |
| PFIZER INC. | 14 | $207 |
| AstraZeneca Pharmaceuticals LP | 7 | $207 |
| Novo Nordisk Inc | 12 | $194 |
| Phathom Pharmaceuticals, Inc. | 3 | $144 |
| Amgen Inc. | 11 | $143 |
| Medtronic, Inc. | 6 | $114 |
| Lilly USA, LLC | 5 | $91 |
| GlaxoSmithKline, LLC. | 5 | $79 |
| Exact Sciences Corporation | 5 | $78 |
Products named: FARXIGA, VOQUEZNA, VRAYLAR, Wegovy, OTEZLA, UBRELVY, MINIMED 780G, MOUNJARO.
Industry payments across KY — which companies pay providers there.
